UNITED THERAPEUTICS Corp · Drugmakers

UTHR

Low riskNext report: In 1 days (est.)

View price ↗

The short version

A high-quality, profitable business with steady sales.

Going well

Profitable, keeps 42% of sales as profit
Sales up 11% last year
Brings in more cash than it spends

Money moves

Insiders sold $118.0M in the last 30 days, all through pre-planned sales
Institutions added 0.9% to their holdings in the quarter ending June 2026 (415 bought, 397 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$592.78+0.9% that day

Company value: $25.4B; Share price times all shares
Price vs profit (P/E): 21.2x; You pay about $21 for each $1 of yearly profit
Price vs sales: 8.1x; Company value is 8.1 times a year of sales
Cash vs value: 7%; Cash as a share of company value

From UTHR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$783.3M-1.9% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $3.2B, up 2.5% from the 12 months before. Over 5 years, sales grew about 17% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of UTHR. Starting points are the company's recent numbers.

Sales growth+2% a yearRecently: +2.5% a yearProfit margin42%Last 12 months: 41.6%P/E at the end21xToday: 21.2x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$3.5B

Profit in 5 years$1.5B

Price these guesses point to$716.20+21% vs $592.78 todayAbout +3.9% a year, before dividends

What today's price needs: with a 42% margin and a 21x P/E, sales could shrink about 1.8% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

6/7Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.19.7%
PassDebt under half of equityNot relying on borrowed money.No debt reported
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.41.9%
MissProfitable every yearSteady profits, not one good year.9 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.0B
PassShare count not growingNot diluting owners. Falling means buybacks.-1.2% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.87.9%

Revenue: $3.2B; +10.6% vs prior year
5-year growth: +16.5%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 6.60x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 5

Revenue: $783.3M; -1.9% YoY
EPS: $7.27; vs $6.41
Op. margin: 42.2%; -3.4 pts
Gross margin: 87.3%; -1.7 pts
Free cash flow: $205.6M
Share count: -5.2%; vs a year ago

Insider rating

Last 90 days

43Mixed

Pre-planned sales of $127.0M (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

39/ 100

This week: 5
Normal week: 8.3
vs normal: 0.6x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+0.9%

Institutions added 0.9% to their holdings. 415 bought, 397 sold.

Shares held by institutions41.8M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-2.9%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

43M

Earnings reports

Last 12

Next reportIn 1 days (est.)Estimated from the same quarter last year

Results filedAug 5
Results filedMay 6
Results filedFeb 25
Results filedOct 29, 2025
Results filedJul 30, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (passive)Aug 14 · View filing ↗Big holder 5%+ holder update (passive)Aug 13 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$122.5M2 insiders, 25 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Martine A RothblattChairperson & CEO	Sell	10K	$588.64	$5.6M	324K	Oct 26Filing ↗
-2.8% of their holdings $585.71 to $592.92 across 8 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$582.76	$5.5M	324K	Oct 23Filing ↗
-2.8% of their holdings $577.68 to $588.00 across 11 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 3 days after
Martine A RothblattChairperson & CEO	Sell	10K	$583.38	$5.5M	324K	Oct 22Filing ↗
-2.8% of their holdings $562.97 to $590.40 across 21 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$560.07	$5.3M	324K	Oct 21Filing ↗
-2.8% of their holdings $552.52 to $566.43 across 14 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$553.87	$5.3M	324K	Oct 20Filing ↗
-2.8% of their holdings $546.84 to $563.56 across 17 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$543.32	$5.2M	324K	Oct 19Filing ↗
-2.8% of their holdings $534.75 to $556.88 across 19 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$534.66	$5.1M	324K	Oct 16Filing ↗
-2.8% of their holdings $530.48 to $543.85 across 13 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 3 days after
Paul A MahonEVP & GENERAL COUNSEL	Sell	8K	$544.30	$4.5M	45K	Oct 15Filing ↗
-15.5% of their holdings $541.64 to $546.56 across 6 trades Pre-planned sale (10b5-1) Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$546.65	$5.2M	324K	Oct 15Filing ↗
-2.8% of their holdings $540.48 to $551.50 across 12 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$539.99	$5.1M	324K	Oct 14Filing ↗
-2.8% of their holdings $526.07 to $546.00 across 16 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$545.52	$5.2M	324K	Oct 13Filing ↗
-2.8% of their holdings $542.76 to $551.49 across 10 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$550.70	$5.2M	324K	Oct 12Filing ↗
-2.8% of their holdings $548.13 to $554.46 across 7 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$544.94	$5.2M	324K	Oct 9Filing ↗
-2.8% of their holdings $531.92 to $550.72 across 17 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 4 days after
Martine A RothblattChairperson & CEO	Sell	10K	$534.31	$5.1M	324K	Oct 8Filing ↗
-2.8% of their holdings $525.50 to $541.23 across 16 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$548.95	$5.2M	324K	Oct 7Filing ↗
-2.8% of their holdings $542.73 to $556.48 across 14 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$538.67	$5.1M	324K	Oct 6Filing ↗
-2.8% of their holdings $527.90 to $545.50 across 17 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$541.64	$5.1M	324K	Oct 5Filing ↗
-2.8% of their holdings $536.26 to $546.63 across 11 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$549.37	$5.2M	324K	Oct 2Filing ↗
-2.8% of their holdings $542.06 to $574.23 across 23 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 3 days after
Paul A MahonEVP & GENERAL COUNSEL	Sell	8K	$564.95	$4.7M	45K	Oct 1Filing ↗
-15.5% of their holdings $558.30 to $573.15 across 10 trades Pre-planned sale (10b5-1) Filed same day
Martine A RothblattChairperson & CEO	Sell	10K	$576.47	$5.5M	324K	Oct 1Filing ↗
-2.8% of their holdings $560.05 to $584.66 across 19 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	2K	$550.22	$1.1M	324K	Sep 30Filing ↗
-0.6% of their holdings $547.29 to $554.70 across 8 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	8K	$517.97	$3.9M	326K	Sep 30Filing ↗
-2.3% of their holdings $476.14 to $546.23 across 24 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$477.42	$4.5M	324K	Sep 29Filing ↗
-2.8% of their holdings $472.05 to $486.77 across 12 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$480.85	$4.6M	324K	Sep 28Filing ↗
-2.8% of their holdings $472.43 to $486.01 across 14 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 1 day after
Martine A RothblattChairperson & CEO	Sell	10K	$476.17	$4.5M	324K	Sep 25Filing ↗
-2.8% of their holdings $470.56 to $478.95 across 9 trades Held via Trust Pre-planned sale (10b5-1) Also Director Filed 3 days after